Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Greatbatch Capacitor Sales, Enpath Purchase Aid 27% Stock Price Jump In Q2

This article was originally published in The Gray Sheet

Executive Summary

Greatbatch's recent surge in ICD capacitor sales and acquisition of implantable stimulation lead manufacturer Enpath helped drive a 27% jump in Greatbatch's stock price in the second quarter

You may also be interested in...



Beckman Coulter Stock Gain Aided By Merger Activity In Diagnostics – Index

Clinical diagnostics firm Beckman Coulter's stock is benefiting from recent merger activity among its rivals in the field and speculation that it too could become an acquisition target; shares advanced 14% in the third quarter to close at $73.76

AMO Lens Solution Recall Will Cut Sales By Up To $120 Million In 2007

The fallout from Advanced Medical Optics' May recall of its Complete MoisturePlus multipurpose contact lens solution will include lost sales of $100 million to $120 million this year, the firm projects

AMO’s Recalled MoisturePlus Lens Solution Had $106 Mil. In Sales Last Year

Advanced Medical Optics is recalling its Complete MoisturePlus contact lens solution after an investigation by the Centers for Disease Control and Prevention found a potential link between the product and a rare eye infection

Related Content

Latest News
See All
UsernamePublicRestriction

Register

MT025023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel